Mulmit

ProPhase Labs, Inc.ProPhase Labs, Inc.

PRPH OTC

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-314,345,000-18,047,000-14,743,000-1.74
2024-12-316,770,000-38,629,000-53,364,000-26.68
2023-12-3134,984,000-21,220,000-16,782,000-0.98
2022-12-31122,647,00023,595,00018,463,0001.02
2021-12-3179,042,0009,801,0006,273,0000.4

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2025-09-09Karkus Ted WilliamCEO & CHAIRMAN500,000
2025-02-17Hollenshead StuartChief Operating Officer500,000
2025-02-14Hirsch Warren100,000
2025-02-14GLECKEL LOUIS MD100,000
2024-03-17Hirsch Warren70,000
2024-03-17GLECKEL LOUIS MD70,000
2024-03-17Barr Jason Michael70,000
2024-03-17Karkus Ted WilliamCEO & CHAIRMAN400,000
2024-01-01Latkin Jed500,000
2023-06-19Hirsch Warren40,000
2023-06-19Barr Jason Michael40,000
2023-06-19GLECKEL LOUIS MD40,000

8-K events

FiledItems
2026-08-06Entry into a material agreement · Creation of a direct financial obligation · Financial statements and exhibits
2026-02-13Other events · Financial statements and exhibits
2026-02-13Other events · Financial statements and exhibits
2026-01-27Other events · Financial statements and exhibits
2026-01-23Other events · Financial statements and exhibits
2026-01-23Entry into a material agreement · Unregistered sales of equity securities · Financial statements and exhibits
2026-01-09Other events · Financial statements and exhibits
2026-01-09Officer or director change
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.